16 results
20-F
2020 FY
AMYT
Amryt Pharma Plc
30 Apr 21
Annual report (foreign)
12:53pm
, or to discontinue the clinical trials altogether;
delays in necessary interactions with local regulators, ethics committees and other important agencies … candidates, we, the FDA, competent authorities of EU Member States, ethics committees, the IRBs, the institutions in which our studies are conducted
424B4
AMYT
Amryt Pharma Plc
14 Jan 21
Prospectus supplement with pricing info
9:30am
altogether;
delays in necessary interactions with local regulators, ethics committees and other important agencies and contractors due to limitations … side effects arise in the development of our product candidates, we, the FDA, competent authorities of EU Member States, ethics committees
F-1/A
AMYT
Amryt Pharma Plc
12 Jan 21
Registration statement (foreign) (amended)
12:00am
, or to discontinue the clinical trials altogether;
delays in necessary interactions with local regulators, ethics committees and other important agencies … Member States, ethics committees, the institutional review boards, at the institutions in which our studies are conducted, or the DSMB, could suspend
F-1
caabrnv2e
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
cjg9prvyxicfm
18 Dec 20
Draft registration statement
12:00am
424B4
du5 5e43ys
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
t7cbwj14q25 mi8v07
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
x89yfgiv5gsgg1 ld
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.12.1
z016qyavc 0dxgj0dum3
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.12.5
dhqu b02osjc42n
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
h2z 7iw074
29 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.12
6tp5g6biecxj80bkquy
11 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.12
z8uboea 4o
11 May 20
Draft registration statement (amended)
12:00am
DRS
1rqmu0 d1ncq3e72q6
19 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next